TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 138 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,684,560 | -0.2% | 524,000 | +71.4% | 0.04% | -10.0% |
| Q2 2023 | $4,694,461 | -27.5% | 305,629 | +6.2% | 0.04% | -35.5% |
| Q1 2023 | $6,471,676 | +839.3% | 287,758 | +929.0% | 0.06% | +933.3% |
| Q3 2022 | $689,000 | -30.8% | 27,964 | -32.0% | 0.01% | -40.0% |
| Q2 2022 | $996,000 | +250.7% | 41,109 | +273.7% | 0.01% | +233.3% |
| Q1 2022 | $284,000 | -30.2% | 11,000 | -16.0% | 0.00% | -25.0% |
| Q4 2021 | $407,000 | +73.2% | 13,100 | +35.1% | 0.00% | +100.0% |
| Q3 2021 | $235,000 | -26.6% | 9,700 | -55.8% | 0.00% | -33.3% |
| Q2 2021 | $320,000 | -90.4% | 21,960 | -82.1% | 0.00% | -93.3% |
| Q4 2020 | $3,348,000 | – | 122,819 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |